The Effect of Intrawound Vancomycin Powder on Surgical Site Infection in Inguinal Lymph Node Dissection
Women and Infants Hospital of Rhode Island
30 participants
Oct 25, 2022
INTERVENTIONAL
Conditions
Summary
The study will be a pilot randomized control trial with a 1:1 patient randomization of vancomycin powder placement at the time of surgery (compared to no vancomycin placement) with the goal of reducing postoperative complications in patients undergoing an inguinal lymph node dissection for vulvar cancer. The primary objective is to measure the composite rate of postoperative complications within 30 days of inguinal lymph node dissection in patients with vulvar cancer.
Eligibility
Inclusion Criteria3
- Women who are undergoing inguinal lymph node dissection for vulvar dysplasia
- Women with a prior lymph node dissection >30 days before
- Women undergoing either a sentinel lymph node biopsy or full lymphadenectomy in a unilateral or bilateral groin dissection
Exclusion Criteria2
- Known allergy to vancomycin
- Known resistance to vancomycin
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The powder will be placed within the surgical wound prior to skin closure.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05625373